Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.57 USD | -1.34% | -12.58% | -26.67% |
09/05 | Wedbush Adjusts Pharvaris' Price Target to $31 From $35, Maintains Outperform Rating | MT |
08/05 | Pharvaris N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.67% | 1.12B | |
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
-2.67% | 12.08B | |
+30.23% | 11.98B |
- Stock Market
- Equities
- PHVS Stock
- News Pharvaris N.V.
- Morgan Stanley Adjusts Price Target on Pharvaris to $32 From $34, Maintains Overweight Rating